Overview
Biyun Zheng practices practicing medicine in China.
Their clinical expertise encompasses Stomach Cancer, Peptic Ulcer, Helicobacter Pylori Infection, and Esophageal Cancer.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
China
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Biyun Zheng
Is Biyun Zheng a top-rated expert for Stomach Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Biyun Zheng is classified as an Experienced expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Biyun Zheng participate in research or clinical trials?
Yes. Biyun Zheng has published 21 articles and abstracts on conditions like Stomach Cancer. You can view a list of Biyun Zheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Esophageal CancerZheng isExperienced. Learn about Esophageal Cancer.
- Helicobacter Pylori InfectionZheng isExperienced. Learn about Helicobacter Pylori Infection.
- Peptic UlcerZheng isExperienced. Learn about Peptic Ulcer.
- Stomach CancerZheng isExperienced. Learn about Stomach Cancer.